Ginkgo Bioworks Holdings Inc (DNA) Stock Analysis
Verdict: AVOID
Persistent revenue contraction and -$180M annual cash burn outweigh strategic AI partnerships, pointing to $5.00 fair value downside.
Investment score: 28/100
Analysis as of
Is Ginkgo Bioworks Holdings Inc stock worth reviewing? AI model thesis
The model views Ginkgo Bioworks as an AVOID due to severe top-line contraction, heavy quarterly cash burn (~-$45M/quarter), and analyst consensus pointing to 47.5% downside.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 65/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 10/100 (weight 10%)
- Analyst Consensus: 15/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
Ginkgo Bioworks Holdings Inc opportunities and risks
What speaks for DNA
- Expansion of Ginkgo Datapoints AI partnerships
What speaks against DNA
- Severe cash burn and limited runway relative to debt obligations
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| DNA | n/a | 5.6x | n/a | 80.1% | -260.0% | -30.6% |
| AZTA | n/a | 2.5x | n/a | 44.0% | -20.0% | 0.6% |
| CYRX | n/a | 4.7x | n/a | 47.1% | -19.5% | -2.3% |
| MLAB | 155.7x | 3.0x | 20.2x | 66.0% | 1.9% | 7.5% |
| CTKB | n/a | 3.5x | n/a | 53.2% | -39.0% | -1.7% |
| OABI | n/a | 17.7x | n/a | 50.5% | -115.2% | -2.7% |
| Peer median | n/a | 3.5x | n/a | 50.5% | -20.0% | -1.7% |
Frequently asked questions about Ginkgo Bioworks Holdings Inc (DNA)
Is DNA stock a good investment?
The cached TradeMates AI model rates Ginkgo Bioworks Holdings Inc as AVOID with an investment score of 28/100. The model views Ginkgo Bioworks as an AVOID due to severe top-line contraction, heavy quarterly cash burn (~-$45M/quarter), and analyst consensus pointing to 47.5% downside. This is algorithmic model output, not personal investment advice.
Is DNA stock a buy?
The TradeMates model verdict for DNA is AVOID with an investment score of 28/100. Treat this as a model signal to review, not a personal buy recommendation.